Michael B. Cook

机构：Manchester Academic Health Science Centre, University of Oxford, Future Science Group (United Kingdom), National Cancer Institute, Imperial College London · ORCID：0000-0002-0533-7302

发表论文 529 篇 · 总被引 15698 次 · h-index 61

代表论文

• Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants (2023 · Nature Genetics · 被引 156)
• Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes (2024 · Journal of the American College of Cardiology · 被引 43)
• Our Future Health: a unique global resource for discovery and translational research (2025 · Nature Medicine · 被引 37)
• Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM (2023 · BMJ Medicine · 被引 28)
• Heterogeneous genetic architectures of prostate cancer susceptibility in sub-Saharan Africa (2024 · Nature Genetics · 被引 21)
• Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab (2024 · Ophthalmology Retina · 被引 18)